A multi-targeting pre-clinical candidate against drug-resistant tuberculosis.
Kaur P, Potluri V, Ahuja VK, Naveenkumar CN, Krishnamurthy RV, Gangadharaiah ST, Shivarudraiah P, Eswaran S, Nirmal CR, Mahizhaveni B, Dusthackeer A, Mondal R, Batt SM, Richardson EJ, Loman NJ, Besra GS, Shandil RK, Narayanan S.
Kaur P, et al. Among authors: shandil rk.
Tuberculosis (Edinb). 2021 Jul;129:102104. doi: 10.1016/j.tube.2021.102104. Epub 2021 Jun 18.
Tuberculosis (Edinb). 2021.
PMID: 34214859